Artivion Recalls CryoPatch SynerGraft Cardiac Patch Over Donor Age Limits
Artivion, Inc. issued a recall for a CryoPatch SynerGraft cardiac patch made from an over-age donor.
Artivion, Inc. has issued a recall for a CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model SGP010.
The recall was initiated because the cryopreserved human tissue was derived from a 64-year-old donor, exceeding the required age specification of newborn to 60 years. Because long-term in vivo data is limited, the possibility of premature graft dysfunction cannot be ruled out for the implanted patch.
The affected product was distributed in Illinois. The recall is being monitored by the U.S. Food and Drug Administration.
What to do
- Consult your healthcare provider if you received a CryoPatch SynerGraft cardiac patch.
- Contact Artivion, Inc. or your medical team to discuss any questions regarding the implant.
- Report any unexpected health issues or adverse events related to the device to the FDA.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0325-2027 |
| Date | 2026-11-11 |
| Company | Artivion, Inc, Kennesaw, GA |
| Severity | Class II |
| Quantity | 1 |
| Where sold | US Nationwide distribution in the state of IL. |
| Lot codes / identifiers | Serial/Donor Number: 12617554/177871, UDI-DI: 00877234000478, Shipped: 22May2024, Implanted: 05June2024 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.